The relationship between serum phenylalanine levels, genotype, and developmental assessment test results in non-phenylketonuria mild hyperphenylalaninemia patients

被引:0
|
作者
Ilguy, Muge [1 ]
Yildirim, Gonca Kilic [2 ]
Eyuboglu, Damla [3 ]
Carman, Kursat Bora [4 ]
Yarar, Coskun [4 ]
机构
[1] Ondokuz Mayis Univ, Div Child Endocrinol, Dept Pediat, Fac Med, Samsun, Turkiye
[2] Eskisehir Osmangazi Univ, Div Child Nutr & Metab, Dept Paediat, Fac Med, Eskisehir, Turkiye
[3] Eskisehir Osmangazi Univ, Dept Child & Adolescent Mental Hlth & Dis, Fac Med, Eskisehir, Turkiye
[4] Eskisehir Osmangazi Univ, Div Child Neurol, Dept Paediat, Fac Med, Eskisehir, Turkiye
关键词
Non-PKU mild hyperphenylalaninemia; Electroencephalogram; Ankara Developmental Screening Inventory; Denver Developmental Screening Test-II; REVISION;
D O I
10.1007/s00431-024-05929-1
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Phenylalanine (PA) levels below 360 mu mol/L do not require treatment; however, cognitive deficits have been observed in patients with elevated PA levels, necessitating a safe upper limit for treatment and therapeutic objectives. The main purpose of this study is to evaluate the correlation between developmental assessments (Denver Developmental Screening Test-II [DDST-II] and Ankara Developmental Screening Inventory [ADSI]) and electroencephalogram (EEG) findings with blood PA levels and genotypic data in non-phenylketonuria mild Hyperphenylalaninemia (HPA) patients, to re-evaluate their treatment status based on potential adverse outcomes. This study encompassed 40 patients aged 1-5 years diagnosed with HPA and not on treatment, identified through initial blood PA levels, and monitored for a minimum of 1 year on an unrestricted diet. Data on demographics, serum PA levels during presentation and follow-up, and genetic mutations were retrieved from hospital records. Patients were categorized into two groups as well-controlled (120-240 mu mol/L) and at-risk (240-360 mu mol/L) based on average PA levels. Sleep-activated EEGs and developmental assessments using the DDST-II and ADSI were conducted to compare outcomes with PA levels and genetic findings. Developmental delays in the DDST-II were observed across language, gross motor, fine motor, and personal-social domains, predominantly in males. No significant difference in delays was noted between the well-controlled and at-risk groups based on PA levels. The ADSI revealed delays in similar developmental areas, with fine motor skills being particularly prominently affected in the at-risk group. Only a well-controlled patient showed abnormal EEG results deemed unrelated to HPA. Conclusion: Our findings indicate that children with untreated PA levels above 240 mu mol/L are particularly susceptible to fine motor skill impairments, suggesting a need to reassess the PA level thresholds for initiating treatment. This study highlights the potential requirement for amending current guidelines to ensure early and appropriate intervention in non-PKU mild HPA patients, thereby mitigating the risk of developmental delays.
引用
收藏
页数:10
相关论文
共 48 条
  • [1] Mutation analysis of the phenylalanine hydroxylase gene and its clinical implications in two Japanese patients with non-phenylketonuria hyperphenylalaninemia
    Masahiro Kibayashi
    M. Nagao
    Shunzo Chiba
    Journal of Human Genetics, 1998, 43 : 231 - 236
  • [2] Neuropsychological assessment among children and adolescents with phenylketonuria and hyperphenylalaninemia and its relationship with plasma phenylalanine levels
    Gonzalez Garcia, Maria B.
    Conde-Guzon, Pablo
    Alcalde Martin, Carlos
    Conde-Guzon, Maria J.
    Velasco Zuniga, Roberto
    ARCHIVOS ARGENTINOS DE PEDIATRIA, 2017, 115 (03): : 267 - 273
  • [3] Diffusion-weighted MR imaging in patients with phenylketonuria: Relationship between serum phenylalanine levels and ADC values in cerebral white matter
    Kono, K
    Okano, Y
    Nakayama, K
    Hase, Y
    Minamikawa, S
    Ozawa, N
    Yokote, H
    Inoue, Y
    RADIOLOGY, 2005, 236 (02) : 630 - 636
  • [4] Genotype Distribution of Hepatitis C Patients among Intravenous Drug users and non-users and Possible Relationship between of Genotype with Serum Aminotransferase Levels
    Oksuz, Zehra
    Ucbilek, Enver
    Serin, Mehmet Sami
    Yaras, Serkan
    Orekici Temel, Gulhan
    Sezgin, Orhan
    FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI, 2022, 27 (01): : 11 - 20
  • [5] Assessment of Relationship Between Serum Vitamin D Levels and Metabolic Syndrome Components in Hemodialysis Patients
    Yilmaz, Sevil Karahan
    Mertoglu, Cuma
    Ayaz, Aylin
    GALICIAN MEDICAL JOURNAL, 2021, 28 (01)
  • [6] Relationship between renal function and serum creatinine levels in patients with cirrhosis.: Relevance for prognosis assessment
    Terra, C.
    Guevara, M.
    Baccaro, M. E.
    Martin-Llahi, M.
    Restuccia, T.
    Torre, A.
    Calahorra, B.
    Arroyo, V.
    Gines, P.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S94 - S94
  • [7] Relationship between Serum Parathyroid Hormone Levels and Lipid Profile in Non-Diabetic Hemodialysis Patients
    Ahmadi, Farokhlagha
    Mirjafari, Seied Reza
    Khatami, Mohammad Reza
    Khazaeipour, Zahra
    Ranjbarnovin, Neda
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2012, 23 (06) : 1188 - 1195
  • [8] Relationship between serum leptin levels, non-cardiovascular risk factors and mortality in hemodialysis patients
    Risovic, Ivona
    Vlatkovic, Vlastimir
    Popovic-Pejicic, Snjezana
    Malesevic, Gabrijela
    ROMANIAN JOURNAL OF INTERNAL MEDICINE, 2021, 59 (02) : 187 - 193
  • [9] The relationship between COPD Assessment Test (CAT) scores and Distress Thermometer (DT) results in COPD patients
    Makuch, Marcelina
    Milanowska, Joanna
    Michnar, Marek
    Makuch, Marcin
    Samardakiewicz, Marzena
    Milanowski, Janusz
    ANNALS OF AGRICULTURAL AND ENVIRONMENTAL MEDICINE, 2020, 27 (04) : 689 - 694
  • [10] INDIVIDUAL ASSESSMENT OF GASTRIC ACID PRODUCTION BY MEANS OF A NON-INVASIVE TEST: RELATIONSHIP BETWEEN MAXIMAL ACID OUTPUT AND SERUM PEPSINOGEN I LEVELS IN PATIENTS WITH DIFFERENT UPPER GI DISEASES
    Di Mario, F.
    Scida, S.
    Miraglia, C.
    Franceschi, M.
    Bertele, A.
    Cannizzaro, R.
    Dal Bo, N.
    Savarino, E.
    De Bortoli, N.
    Rugge, M.
    Scarpignato, C.
    DIGESTIVE AND LIVER DISEASE, 2017, 49 : E138 - E138